Status:
RECRUITING
Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)
Lead Sponsor:
University Hospital, Brest
Conditions:
Venous Thromboembolism (VTE)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and/or pulmonary embolism (PE), is a major public health issue. VTE is the third most common acute cardiovascular pathology, aft...
Eligibility Criteria
Inclusion
- Major patient (≥18 years), voluntary blood donor, with no notable medical history altering coagulation (i.e. known thrombophilia, active cancer), no chronic pathology, no current treatment.
Exclusion
- Minor patient (\<18 years); known chronic pathology; long-term treatment including anti-platelet aggregation therapy or anticoagulant treatment, refusal to participate.
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06057844
Start Date
February 27 2024
End Date
August 1 2025
Last Update
March 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etablissement francais du sang
Brest, France, 29200